Stockscreener 앱 받기
7.12
7.29%
-0.56
전일 마감가:
$7.68
열려 있는:
$7.64
하루 거래량:
369.62K
Relative Volume:
1.96
시가총액:
$607.08M
수익:
-
순이익/손실:
$-29.64M
주가수익비율:
-16.56
EPS:
-0.43
순현금흐름:
$-39.43M
1주 성능:
+2.74%
1개월 성능:
+38.52%
6개월 성능:
+131.92%
1년 성능:
+82.56%
1일 변동 폭
$7.00
$7.64
1주일 범위
$6.45
$7.89
52주 변동 폭
$2.30
$7.89
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
DRTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
7.12 | 654.83M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Analyst Calls: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly pricedEarnings Summary Report & Safe Entry Zone Tips - baoquankhu1.vn
Guidance Update: Is Alpha Tau Medical Ltd Equity Warrant in a consolidation phaseQuarterly Portfolio Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
DRTS: Pivotal trials advance for Alpha DaRT, with strong data and U.S. commercialization plans in place - TradingView — Track All Markets
DRTS: Pivotal trials and manufacturing scale-up position Alpha DaRT for major milestones in 2026 - TradingView — Track All Markets
DRTS: Transformative alpha-based cancer therapy nears pivotal data and regulatory milestones in 2024 - TradingView — Track All Markets
Sentiment Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpWhat's Next? - MarketBeat
TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday - Benzinga
Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High – Here’s Why - Defense World
Aug Decliners: Why is Alpha Tau Medical Ltd stock going downQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright - Investing.com UK
Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright By Investing.com - Investing.com South Africa
Alpha Tau Medical Ltd.Ordinary Shares (NQ: DRTS - FinancialContent
Alpha Tau files first FDA PMA module for Alpha DaRT skin cancer therapy - MSN
Is Alpha Tau Medical Ltd. stock positioned well for digital economyJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockQuarterly Portfolio Summary & Step-by-Step Swing Trade Plans - Улправда
Is Alpha Tau Medical Ltd. stock positioned for long term growthChart Signals & Precise Swing Trade Entry Alerts - Улправда
Value Recap: Will Alpha Tau Medical Ltd. stock attract ESG investors2025 Technical Patterns & Daily Growth Stock Investment Tips - Улправда
Will Alpha Tau Medical Ltd. stock deliver strong dividend growthWall Street Watch & Low Risk Entry Point Tips - ulpravda.ru
Is Alpha Tau Medical Ltd. stock cheap at current valuationPerformance Line Overview & what to check before ordering - ulpravda.ru
How risky is Alpha Tau Medical Ltd. Equity Warrant stock nowMarket Performance Summary & Consistent Profit Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. stock pay special dividendsJuly 2025 Levels & Safe Swing Trade Setups - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver better than expected guidanceJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - Улправда
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spending2025 Trading Recap & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock supported by strong cash flowsMarket Sentiment Summary & Reliable Momentum Entry Alerts - Улправда
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratiosQuarterly Portfolio Report & High Win Rate Trade Tips - Улправда
Is Alpha Tau Medical Ltd. stock a buy in volatile marketsEarnings Performance Report & Fast Gain Swing Trade Alerts - ulpravda.ru
Is Alpha Tau Medical Ltd. stock supported by strong fundamentalsProfit Target & Safe Entry Trade Signal Reports - ulpravda.ru
Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Why Alpha Tau Medical Ltd. stock remains a top recommendation2025 Year in Review & Free Weekly Watchlist of Top Performers - Улправда
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's Why - MarketBeat
Dental EconomicsAlpha Tau Medical Ltd.Ordinary Shares (Nasdaq:DRTS) Price Chart - FinancialContent
Alpha Tau Medical to present corporate update at JP Morgan 2026 Healthcare Conference - MSN
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com South Africa
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau reports new positive results in two upcoming presentations - marketscreener.com
Pancreatic cancer trial finds immune-sparing radiation with 81% disease control - Stock Titan
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com Nigeria
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical - TipRanks
Daily News - FinancialContent
Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation - The Globe and Mail
Bond Watch: Is Alpha Tau Medical Ltd stock a buy before product launchesJuly 2025 Gainers & Long-Term Capital Growth Strategies - Bộ Nội Vụ
Alpha Tau submits first pre-market approval module to the FDA - marketscreener.com
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy - TipRanks
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) - The Manila Times
Alpha Tau submits PMA module to FDA for Alpha DaRT - TipRanks
Pasadena Star News - FinancialContent
What drives Alpha Tau Medical Ltd stock priceSwing Trading Watchlist & High Return Capital Gains - earlytimes.in
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):